Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/223112
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPeremiquel Trillas, Paula-
dc.contributor.authorRoura Fornells, Esther-
dc.contributor.authorRangel Sarmiento, Valentina-
dc.contributor.authorMorey, Francisca-
dc.contributor.authorFont, Rebeca-
dc.contributor.authorCarvajal Restoy, Maite-
dc.contributor.authorRobles, Claudia-
dc.contributor.authorIbáñez, Raquel-
dc.contributor.authorPijuan, Lara-
dc.contributor.authorTamarit, Lourdes-
dc.contributor.authorCortasa, Dolça-
dc.contributor.authorFernández, Daniel-
dc.contributor.authorAlfons Espinàs, Josep-
dc.contributor.authorBruni, Laia-
dc.contributor.authorThe Catalan Cervical Cancer Screening Program Working Group-
dc.date.accessioned2025-09-12T07:05:44Z-
dc.date.available2025-09-12T07:05:44Z-
dc.date.issued2025-08-04-
dc.identifier.issn2296-858X-
dc.identifier.urihttps://hdl.handle.net/2445/223112-
dc.description.abstractIntroduction As part of the transition from opportunistic cytology-based screening to an organized, population-based HPV screening program, Catalonia, Spain, launched an implementation pilot in 2021.Methods The pilot combined home-based HPV self-sampling with pharmacy-based distribution, coordinated by a screening office using an SMS-based invitation and reminder system, alongside structured follow-up of HPV-positive cases by midwives.Results From July 2021 to December 2023, 6,355 women seeking cervical cancer screening were invited to participate in HPV self-sampling via SMS, with high participation (80.9%). Among HPV-positive women (11.8%), compliance with triage cytology was high (98.7%), as with colposcopy referrals when indicated (97.2%). CIN2+ detection rates (3.6% overall, 13.1% in HPV-16 positive) aligned with international studies, reinforcing the value of genotype-specific risk stratification and risk-adapted follow-up pathways in our setting. This organized approach facilitated timely case management and demonstrated the feasibility, acceptability, and effectiveness of the model.Discussion While conducted in an opportunistic screening context with a relatively short follow-up time, these findings support HPV self-sampling as an effective primary screening strategy, including women who regularly attend cervical cancer screening, and provide key insights for its scalability within a population-based program, which began its pilot phase in 2024 and is set for full implementation in 2025.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFrontiers Media SA-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fmed.2025.1580665-
dc.relation.ispartofFrontiers in Medicine, 2025, vol. 12-
dc.relation.urihttps://doi.org/10.3389/fmed.2025.1580665-
dc.rightscc-by (c) Peremiquel Trillas, Paula et al., 2025-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationCàncer de coll uterí-
dc.subject.classificationPapil·lomavirus-
dc.subject.classificationCribratge-
dc.subject.otherCervix cancer-
dc.subject.otherPapillomaviruses-
dc.subject.otherMedical screening-
dc.titleBuilding the foundations for an organized population-based cervical cancer screening program with primary HPV self-sampling in Catalonia, Spain: findings from a pilot implementation study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2025-09-10T08:12:05Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid40832106-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
fmed-4-1580665.pdf4.96 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons